drugset / Trial / NCT00547417

To Determine Effect and Safety of Tadalafil Taken by Men of Different Races and With Different Diseases When Needed for Erections

NCT00547417

Phase 3 Completed 1933 enrolled Eli Lilly and Company ICOS Corporation · collab
NaSingle-groupOpen-labelTreatment

Summary

To compare men of different races and those with diabetes or depression to white men that do not have diabetes or depression but also suffer from the inability to get or keep an erection.

Timeline

Start
2003-07
Primary completion
Completion
2004-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Tadalafil Small molecule 20 mg Oral

Indications